File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Epstein-Barr virus–positive diffuse large B-cell lymphoma after frontline brentuximab vedotin treatment of classical Hodgkin lymphoma

TitleEpstein-Barr virus–positive diffuse large B-cell lymphoma after frontline brentuximab vedotin treatment of classical Hodgkin lymphoma
Authors
Tse, EWCAu Yeung, KHRChau, HWDHwang, YYGLoong, FKwong, YL
Issue Date2022
Citation
Annals of Hematology, 2022, v. 101, p. 1149-1152 How to Cite?
DOI: http://dx.doi.org/10.1007/s00277-021-04709-3
Persistent Identifierhttp://hdl.handle.net/10722/322283
ISI Accession Number ID
WOS:000716854900001

 

DC FieldValueLanguage
dc.contributor.authorTse, EWC-
dc.contributor.authorAu Yeung, KHR-
dc.contributor.authorChau, HWD-
dc.contributor.authorHwang, YYG-
dc.contributor.authorLoong, F-
dc.contributor.authorKwong, YL-
dc.date.accessioned2022-11-14T08:18:56Z-
dc.date.available2022-11-14T08:18:56Z-
dc.date.issued2022-
dc.identifier.citationAnnals of Hematology, 2022, v. 101, p. 1149-1152-
dc.identifier.urihttp://hdl.handle.net/10722/322283-
dc.languageeng-
dc.relation.ispartofAnnals of Hematology-
dc.titleEpstein-Barr virus–positive diffuse large B-cell lymphoma after frontline brentuximab vedotin treatment of classical Hodgkin lymphoma-
dc.typeArticle-
dc.identifier.emailTse, EWC: ewctse@hku.hk-
dc.identifier.emailAu Yeung, KHR: rex.auyeung@hku.hk-
dc.identifier.emailChau, HWD: dhwchau@hku.hk-
dc.identifier.emailKwong, YL: ylkwong@hkucc.hku.hk-
dc.identifier.authorityTse, EWC=rp00471-
dc.identifier.authorityAu Yeung, KHR=rp01877-
dc.identifier.authorityKwong, YL=rp00358-
dc.identifier.doi10.1007/s00277-021-04709-3-
dc.identifier.hkuros341640-
dc.identifier.volume101-
dc.identifier.spage1149-
dc.identifier.epage1152-
dc.identifier.isiWOS:000716854900001-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats